<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD10490000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P09211</UniProt_ID>
  <Seq_Length>210</Seq_Length>
  <Molecule_Weight>23356</Molecule_Weight>
  <KEGG_ID>hsa:2950</KEGG_ID>
  <Orthology_ID>K00799</Orthology_ID>
  <EBI_ID>EBI-353467</EBI_ID>
  <Function_Summary>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration.</Function_Summary>
  <Catalytic_Mechanism>RX + glutathione = HX + R-S-glutathione.</Catalytic_Mechanism>
  <Pfam_ID>PF00043:GST_C@@PF02798:GST_N</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>GSTP1-1</Alias>
      <Alias>GST class-pi</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with nitric oxide (NO).</Detail>
      <Keyword>Nitric oxide binding</Keyword>
      <Ontology_ID>GO:0070026</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: R-X + glutathione = H-X + R-S-glutathione. R may be an aliphatic, aromatic or heterocyclic group; X may be a sulfate, nitrile or halide group.</Detail>
      <Keyword>Glutathione transferase activity</Keyword>
      <Ontology_ID>GO:0004364</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Modulates the activity of a kinase, an enzyme which catalyzes of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase regulator activity</Keyword>
      <Ontology_ID>GO:0019207</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with JUN kinase, an enzyme that catalyzes the phosphorylation and activation of members of the JUN family.</Detail>
      <Keyword>JUN kinase binding</Keyword>
      <Ontology_ID>GO:0008432</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>114</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>169</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>105</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 beta production.</Detail>
      <Keyword>Negative regulation of interleukin-1 beta production</Keyword>
      <Ontology_ID>GO:0032691</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process whose specific outcome is the progression of the central nervous system over time, from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain, spinal cord and spinal nerves. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.</Detail>
      <Keyword>Central nervous system development</Keyword>
      <Ontology_ID>GO:0007417</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate, or extent of an acute inflammatory response.</Detail>
      <Keyword>Negative regulation of acute inflammatory response</Keyword>
      <Ontology_ID>GO:0002674</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving glutathione, the tripeptide glutamylcysteinylglycine, which acts as a coenzyme for some enzymes and as an antioxidant in the protection of sulfhydryl groups in enzymes and other proteins; it has a specific role in the reduction of hydrogen peroxide (H2O2) and oxidized ascorbate, and it participates in the gamma-glutamyl cycle.</Detail>
      <Keyword>Glutathione metabolic process</Keyword>
      <Ontology_ID>GO:0006749</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.</Detail>
      <Keyword>Response to reactive oxygen species</Keyword>
      <Ontology_ID>GO:0000302</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of leukocyte proliferation.</Detail>
      <Keyword>Negative regulation of leukocyte proliferation</Keyword>
      <Ontology_ID>GO:0070664</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells.</Detail>
      <Keyword>Negative regulation of fibroblast proliferation</Keyword>
      <Ontology_ID>GO:0048147</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the rate, frequency or extent of necrotic cell death. Necrotic cell death is a cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.</Detail>
      <Keyword>Negative regulation of necrotic cell death</Keyword>
      <Ontology_ID>GO:0060547</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of an I-kappaB kinase/NF-kappaB induced cascade.</Detail>
      <Keyword>Negative regulation of I-kappaB kinase/NF-kappaB cascade</Keyword>
      <Ontology_ID>GO:0043124</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.</Detail>
      <Keyword>Cellular response to lipopolysaccharide</Keyword>
      <Ontology_ID>GO:0071222</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.</Detail>
      <Keyword>Negative regulation of ERK1 and ERK2 cascade</Keyword>
      <Ontology_ID>GO:0070373</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.</Detail>
      <Keyword>Negative regulation of stress-activated MAPK cascade</Keyword>
      <Ontology_ID>GO:0032873</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate, or extent of production of monocyte chemotactic protein-1.</Detail>
      <Keyword>Negative regulation of monocyte chemotactic protein-1 production</Keyword>
      <Ontology_ID>GO:0071638</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.</Detail>
      <Keyword>Negative regulation of tumor necrosis factor production</Keyword>
      <Ontology_ID>GO:0032720</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptosis.</Detail>
      <Keyword>Negative regulation of apoptosis</Keyword>
      <Ontology_ID>GO:0043066</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of the enzyme nitric-oxide synthase.</Detail>
      <Keyword>Negative regulation of nitric-oxide synthase biosynthetic process</Keyword>
      <Ontology_ID>GO:0051771</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of JUN kinase activity.</Detail>
      <Keyword>Negative regulation of JUN kinase activity</Keyword>
      <Ontology_ID>GO:0043508</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor.</Detail>
      <Keyword>Negative regulation of tumor necrosis factor-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0010804</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving a xenobiotic compound, a compound foreign to living organisms. Used of chemical compounds, e.g. a xenobiotic chemical, such as a pesticide.</Detail>
      <Keyword>Xenobiotic metabolic process</Keyword>
      <Ontology_ID>GO:0006805</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.</Detail>
      <Keyword>Positive regulation of superoxide anion generation</Keyword>
      <Ontology_ID>GO:0032930</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>4</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>199</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>128</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>109</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGDLTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYVKALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAYVGRLSARPKLKAFLASPEYVNLPINGNGKQ</Protein_Seq>
    <DNA_Seq>TGGGAAAGAGGGAAAGGCTTCCCCGGCCAGCTGCGCGGCGACTCCGGGGACTCCAGGGCGCCCCTCTGCGGCCGACGCCCGGGGTGCAGCGGCCGCCGGGGCTGGGGCCGGCGGGAGTCCGCGGGACCCTCCAGAAGAGCGGCCGGCGCCGTGACTCAGCACTGGGGCGGAGCGGGGCGGGACCACCCTTATAAGGCTCGGAGGCCGCGAGGCCTTCGCTGGAGTTTCGCCGCCGCAGTCTTCGCCACCATGCCGCCCTACACCGTGGTCTATTTCCCAGTTCGAGGCCGCTGCGCGGCCCTGCGCATGCTGCTGGCAGATCAGGGCCAGAGCTGGAAGGAGGAGGTGGTGACCGTGGAGACGTGGCAGGAGGGCTCACTCAAAGCCTCCTGCCTATACGGGCAGCTCCCCAAGTTCCAGGACGGAGACCTCACCCTGTACCAGTCCAATACCATCCTGCGTCACCTGGGCCGCACCCTTGGGCTCTATGGGAAGGACCAGCAGGAGGCAGCCCTGGTGGACATGGTGAATGACGGCGTGGAGGACCTCCGCTGCAAATACATCTCCCTCATCTACACCAACTATGAGGCGGGCAAGGATGACTATGTGAAGGCACTGCCCGGGCAACTGAAGCCTTTTGAGACCCTGCTGTCCCAGAACCAGGGAGGCAAGACCTTCATTGTGGGAGACCAGATCTCCTTCGCTGACTACAACCTGCTGGACTTGCTGCTGATCCATGAGGTCCTAGCCCCTGGCTGCCTGGATGCGTTCCCCCTGCTCTCAGCATATGTGGGGCGCCTCAGTGCCCGGCCCAAGCTCAAGGCCTTCCTGGCCTCCCCTGAGTACGTGAACCTCCCCATCAATGGCAACGGGAAACAGTGAGGGTTGGGGGGACTCTGAGCGGGAGGCAGAGTTTGCCTTCCTTTCTCCAGGACCAATAAAATTTCTAAGAGAGCTAAAAAAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Mitochondrion</CellLocal>
      <Ontology_ID>GO:0005739</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>GSTP1</Gene_Name>
    <Gene_Alias>FAEES3; GST3</Gene_Alias>
    <Gene_ID>2950</Gene_ID>
    <Genbank_ACCN>NM_000852</Genbank_ACCN>
    <Protein_ACCN>NP_000843</Protein_ACCN>
    <HGNC_ID>4638</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/2950</Gene_URL>
    <UCSC_ID>uc001omf.3</UCSC_ID>
    <EMBL_ID>ENSG00000084207</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q12933</Uniprot_ID>
      <Gene_Name>TRAF2</Gene_Name>
      <EBI_ID>EBI-355744</EBI_ID>
      <PPI_EBI_URL>EBI-353467,EBI-355744</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Breast Cancer</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS047</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_cancer?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Multiple Chemical Sensitivity</Disease_Name>
      <Disease_Detail>Multiple Chemical Sensitivity</Disease_Detail>
      <Disease_DB>MLT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/multiple_chemical_sensitivity?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pre-Eclampsia</Disease_Name>
      <Disease_Detail>Pre-Eclampsia</Disease_Detail>
      <Disease_DB>PRC016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pre_eclampsia?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Oral Cancer</Disease_Name>
      <Disease_Detail>Oral Cancer</Disease_Detail>
      <Disease_DB>ORL011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/oral_cancer?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Plasmodium Vivax Malaria</Disease_Name>
      <Disease_Detail>Plasmodium Vivax Malaria</Disease_Detail>
      <Disease_DB>PLS006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/plasmodium_vivax_malaria?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardia Cancer</Disease_Name>
      <Disease_Detail>Cardia Cancer</Disease_Detail>
      <Disease_DB>CRD005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardia_cancer?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Maxillary Sinus Squamous Cell Carcinoma</Disease_Name>
      <Disease_Detail>Maxillary Sinus Squamous Cell Carcinoma</Disease_Detail>
      <Disease_DB>MXL004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/maxillary_sinus_squamous_cell_carcinoma?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bladder Cancer Susceptibility</Disease_Name>
      <Disease_Detail>Bladder Cancer</Disease_Detail>
      <Disease_DB>BLD101</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bladder_cancer_susceptibility?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Barrett's Esophagus</Disease_Name>
      <Disease_Detail>Barrett's Esophagus</Disease_Detail>
      <Disease_DB>BRR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/barretts_esophagus?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Diffuse Gastric Cancer</Disease_Name>
      <Disease_Detail>Diffuse Gastric Cancer</Disease_Detail>
      <Disease_DB>DFF019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/diffuse_gastric_cancer?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Epstein-Barr Virus-Associated Gastric Carcinoma</Disease_Name>
      <Disease_Detail>Epstein-Barr Virus-Associated Gastric Carcinoma</Disease_Detail>
      <Disease_DB>EPS023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/epstein_barr_virus_associated_gastric_carcinoma?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hereditary Pancreatitis</Disease_Name>
      <Disease_Detail>Hereditary Pancreatitis</Disease_Detail>
      <Disease_DB>HRD057</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hereditary_pancreatitis?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Eclampsia</Disease_Name>
      <Disease_Detail>Eclampsia</Disease_Detail>
      <Disease_DB>ECL001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/eclampsia?search=GSTP1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Exfoliation Syndrome</Disease_Name>
      <Disease_Detail>Exfoliation Syndrome</Disease_Detail>
      <Disease_DB>EXF001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/exfoliation_syndrome?search=GSTP1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HGSTP1-1[I104] COMPLEXED WITH THE GSH CONJUGATE OF (+)-ANTI-BPDE</PDB_Title>
      <PDB_ID>3PGT</PDB_ID>
      <Resolution>2.14</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3PGT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure and function of residue 104 and water molecules in the xenobiotic substrate-binding site in human glutathione S-transferase P1-1.</PubMed_Title>
      <Author>Ji, X., et al.</Author>
      <Journal>Biochemistry(1999)38:10231-10238</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10441116?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE S-TRANSFERASE IN COMPLEX WITH P-BROMOBENZYLGLUTATHIONE</PDB_Title>
      <PDB_ID>1AQV</PDB_ID>
      <Resolution>1.94</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1AQV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor.</PubMed_Title>
      <Author>Prade, L., et al.</Author>
      <Journal>Structure(1997)5:1287-1295</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9351803?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE S-TRANSFERASE IN COMPLEX WITH MEISENHEIMER COMPLEX</PDB_Title>
      <PDB_ID>1AQX</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1AQX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor.</PubMed_Title>
      <Author>Prade, L., et al.</Author>
      <Journal>Structure(1997)5:1287-1295</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9351803?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH GLUTATHIONE</PDB_Title>
      <PDB_ID>6GSS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=6GSS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1997)274:84-100</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9398518?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal strcture of human Pi class glutathione S-transferase GSTP1-1 in complex with 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX)</PDB_Title>
      <PDB_ID>3GUS</PDB_ID>
      <Resolution>1.53</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GUS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases</PubMed_Title>
      <Author>Federici, L., et al.</Author>
      <Journal>Cancer Res.(2009)69:8025-8034</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19808963?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Glutathione Transferase Pi in complex with S-nitrosoglutathione</PDB_Title>
      <PDB_ID>2A2R</PDB_ID>
      <Resolution>1.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2A2R</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Calorimetric and structural studies of the nitric oxide carrier S-nitrosoglutathione bound to human glutathione transferase P1-1</PubMed_Title>
      <Author>Tellez-Sanz, R., et al.</Author>
      <Journal>Protein Sci.(2006)15:1093-1105</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16597834?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE S-TRANSFERASE COMPLEXED WITH SULFASALAZINE</PDB_Title>
      <PDB_ID>13GS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=13GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Ligandin (Non-Substrate) Binding Site of Human Pi Class Glutathione Transferase is Located in the Electrophile Binding Site (H-Site).</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1999)291:913</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10452896?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE-S-TRANSFERASE P1-1 CYS-FREE MUTANT IN COMPLEX WITH S-HEXYLGLUTATHIONE AT 2.4 A RESOLUTION</PDB_Title>
      <PDB_ID>2J9H</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2J9H</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Modulating Catalytic Activity by Unnatural Amino Acid Residues in a Gsh-Binding Loop of Gst P1-1.</PubMed_Title>
      <Author>Hegazy, U.M., et al.</Author>
      <Journal>J.Mol.Biol.(2008)376:811</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18177897?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE S-TRANSFERASE P1-1</PDB_Title>
      <PDB_ID>17GS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=17GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Glutathione S-transferase P1-1</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>A folding mutant of human class pi glutathione transferase, created by mutating glycine 146 of the wild-type protein to valine</PDB_Title>
      <PDB_ID>1MD4</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1MD4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Contribution of Glycine 146 to a Conserved Folding Module Affecting Stability and Refolding of Human Glutathione Transferase P1-1</PubMed_Title>
      <Author>Kong, G.K.-W., et al.</Author>
      <Journal>J.Biol.Chem.(2003)278:1291-1302</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12414796?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH TER117</PDB_Title>
      <PDB_ID>10GS</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=10GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1997)274:84-100</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9398518?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Glutathione Transferase Pi in complex with the Chlorambucil-Glutathione Conjugate</PDB_Title>
      <PDB_ID>3CSH</PDB_ID>
      <Resolution>1.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CSH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants.</PubMed_Title>
      <Author>Parker, L.J., et al.</Author>
      <Journal>J.Mol.Biol.(2008)380:131-144</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18511072?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>THREE-DIMENSIONAL STRUCTURE OF CLASS PI GLUTATHIONE S-TRANSFERASE FROM HUMAN PLACENTA IN COMPLEX WITH S-HEXYLGLUTATHIONE AT 2.8 ANGSTROMS RESOLUTION</PDB_Title>
      <PDB_ID>1GSS</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1GSS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Three-dimensional structure of class pi glutathione S-transferase from human placenta in complex with S-hexylglutathione at 2.8 A resolution.</PubMed_Title>
      <Author>Reinemer, P., et al.</Author>
      <Journal>J.Mol.Biol.(1992)227:214-226</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/1522586?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE S-TRANSFERASE P1-1[V104] COMPLEXED WITH (9R,10R)-9-(S-GLUTATHIONYL)-10-HYDROXY-9,10-DIHYDROPHENANTHRENE</PDB_Title>
      <PDB_ID>2PGT</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2PGT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure and function of the xenobiotic substrate-binding site and location of a potential non-substrate-binding site in a class pi glutathione S-transferase.</PubMed_Title>
      <Author>Ji, X., et al.</Author>
      <Journal>Biochemistry(1997)36:9690-9702</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9245401?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of human Glutathione Transferase Pi class in complex with Ethacraplatin</PDB_Title>
      <PDB_ID>3N9J</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3N9J</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Studies of glutathione transferase P1-1 bound to a platinum(IV)-based anticancer compound reveal the molecular basis of its activation.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Human glutathione S-transferase P1-1, complex with glutathione</PDB_Title>
      <PDB_ID>7GSS</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=7GSS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1997)274:84-100</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9398518?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE S-TRANSFERASE P1-1 APO FORM 3</PDB_Title>
      <PDB_ID>16GS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=16GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Evidence for an induced-fit mechanism operating in pi class glutathione transferases.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>Biochemistry(1998)37:9912-9917</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9665696?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A folding mutant of human class pi glutathione transferase, created by mutating glycine 146 of the wild-type protein to alanine</PDB_Title>
      <PDB_ID>1MD3</PDB_ID>
      <Resolution>2.03</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1MD3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Contribution of Glycine 146 to a Conserved Folding Module Affecting Stability and Refolding of Human Glutathione Transferase P1-1</PubMed_Title>
      <Author>Kong, G.K.-W., et al.</Author>
      <Journal>J.Biol.Chem.(2003)278:1291-1302</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12414796?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE S-TRANSFERASE COMPLEXED WITH S-NONYL-GLUTATHIONE</PDB_Title>
      <PDB_ID>12GS</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=12GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The Ligandin (Non-Substrate) Binding Site of Human Pi Class Glutathione Transferase is Located in the Electrophile Binding Site (H-Site).</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1999)291:913</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10452896?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH GLUTATHIONE</PDB_Title>
      <PDB_ID>5GSS</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=5GSS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1997)274:84-100</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9398518?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Glutathione Transferase Pi enzyme in complex with the bifunctional inhibitor, Etharapta</PDB_Title>
      <PDB_ID>3DD3</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DD3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Rational design of an organometallic glutathione transferase inhibitor</PubMed_Title>
      <Author>Ang, W.H., et al.</Author>
      <Journal>Angew.Chem.Int.Ed.Engl.(2009)48:3854-3857</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19396894?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN GLUTATHIONE S-TRANSFERASE P1-1, COMPLEX WITH S-HEXYL GLUTATHIONE</PDB_Title>
      <PDB_ID>9GSS</PDB_ID>
      <Resolution>1.97</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=9GSS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1997)274:84-100</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9398518?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human glutathione s-transferase p1-1 in complex with chlorambucil</PDB_Title>
      <PDB_ID>3CSJ</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CSJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants.</PubMed_Title>
      <Author>Parker, L.J., et al.</Author>
      <Journal>J.Mol.Biol.(2008)380:131-144</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18511072?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Glutathione s-transferase complexed with ethacrynic acid-glutathione conjugate (form ii)</PDB_Title>
      <PDB_ID>11GS</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=11GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The glutathione conjugate of ethacrynic acid can bind to human pi class glutathione transferase P1-1 in two different modes.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>FEBS Lett.(1997)419:32-36</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9426214?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Glutathione Transferase Pi Y108V Mutant</PDB_Title>
      <PDB_ID>3HKR</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HKR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Influence of the H-site residue 108 on human glutathione transferase P1-1 ligand binding: structure-thermodynamic relationships and thermal stability.</PubMed_Title>
      <Author>Quesada-Soriano, I., et al.</Author>
      <Journal>Protein Sci.(2009)18:2454-2470</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19780048?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Human Glutathione Transferase in complex with S-nitrosoglutathione in the absence of reducing agent</PDB_Title>
      <PDB_ID>2A2S</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2A2S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Calorimetric and structural studies of the nitric oxide carrier S-nitrosoglutathione bound to human glutathione transferase P1-1</PubMed_Title>
      <Author>Tellez-Sanz, R., et al.</Author>
      <Journal>Protein Sci.(2006)15:1093-1105</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16597834?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE S-TRANSFERASE P1-1 COMPLEXED WITH 1-(S-GLUTATHIONYL)-2,4-DINITROBENZENE</PDB_Title>
      <PDB_ID>18GS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=18GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The ligandin (non-substrate) binding site of human Pi class glutathione transferase is located in the electrophile binding site (H-site).</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1999)291:913-926</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10452896?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN GLUTATHIONE S-TRANSFERASE P1-1 Y49F MUTANT</PDB_Title>
      <PDB_ID>22GS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=22GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Thermodynamic description of the effect of the mutation Y49F on human glutathione transferase P1-1 in binding with glutathione and the inhibitor S-hexylglutathione.</PubMed_Title>
      <Author>Ortiz-Salmeron, E., et al.</Author>
      <Journal>J.Biol.Chem.(2003)278:46938-46948</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12937169?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE TRANSFERASE P1-1</PDB_Title>
      <PDB_ID>1EOH</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1EOH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of thermolabile mutants of human glutathione transferase P1-1.</PubMed_Title>
      <Author>Rossjohn, J., et al.</Author>
      <Journal>J.Mol.Biol.(2000)302:295-302</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10970734?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE S-TRANSFERASE P1-1[V104] COMPLEXED WITH S-HEXYLGLUTATHIONE</PDB_Title>
      <PDB_ID>1PGT</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PGT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure and function of the xenobiotic substrate-binding site and location of a potential non-substrate-binding site in a class pi glutathione S-transferase.</PubMed_Title>
      <Author>Ji, X., et al.</Author>
      <Journal>Biochemistry(1997)36:9690-9702</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9245401?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Glutathione transferase mutant</PDB_Title>
      <PDB_ID>1KBN</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KBN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of Glutathione transferase mutant</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Glutathione s-transferase p1-1</PDB_Title>
      <PDB_ID>19GS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=19GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The ligandin (non-substrate) binding site of human Pi class glutathione transferase is located in the electrophile binding site (H-site).</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1999)291:913-926</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10452896?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human glutathione S-transferase P1-1, complex with glutathione</PDB_Title>
      <PDB_ID>8GSS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=8GSS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1997)274:84-100</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9398518?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A folding mutant of human class pi glutathione transferase, created by mutating aspartate 153 of the wild-type protein to asparagine</PDB_Title>
      <PDB_ID>1PX6</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PX6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The multi-functional role of a highly conserved aspartic acid residue in glutathione transferase P1-1</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Glutathione Transferase Pi allelic variant*C, I104V/A113V, in complex with the Chlorambucil-Glutathione Conjugate</PDB_Title>
      <PDB_ID>3CSI</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CSI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants.</PubMed_Title>
      <Author>Parker, L.J., et al.</Author>
      <Journal>J.Mol.Biol.(2008)380:131-144</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18511072?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of a recombinant glutathione transferase, created by replacing the last seven residues of each subunit of the human class pi isoenzyme with the additional C-terminal helix of human class alpha isoenzyme</PDB_Title>
      <PDB_ID>1LBK</PDB_ID>
      <Resolution>1.86</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1LBK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Engineering a new C-terminal tail in the H-site of human glutathione transferase P1-1: structural and functional consequences.</PubMed_Title>
      <Author>Micaloni, C., et al.</Author>
      <Journal>J.Mol.Biol.(2003)325:111-122</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12473455?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Human GST Pi C47S/Y108V Double Mutant in Complex with the Ethacrynic Acid-Glutathione Conjugate (Grown in the Absence of the Reducing Agent DTT)</PDB_Title>
      <PDB_ID>3KMO</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KMO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Diuretic drug binding to human glutathione transferase P1-1: potential role of CYS101 revealed in the double mutant C47S/Y108V</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF HGSTP1-1[V104] COMPLEXED WITH THE GSH CONJUGATE OF (+)-ANTI-BPDE</PDB_Title>
      <PDB_ID>4PGT</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4PGT</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure and function of residue 104 and water molecules in the xenobiotic substrate-binding site in human glutathione S-transferase P1-1.</PubMed_Title>
      <Author>Ji, X., et al.</Author>
      <Journal>Biochemistry(1999)38:10231-10238</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10441116?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of Glutathione Transferase Pi Y108V Mutant in Complex with the Glutathione Conjugate of Ethacrynic Acid</PDB_Title>
      <PDB_ID>3HJO</PDB_ID>
      <Resolution>1.95</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HJO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Influence of the H-site residue 108 on human glutathione transferase P1-1 ligand binding: structure-thermodynamic relationships and thermal stability.</PubMed_Title>
      <Author>Quesada-Soriano, I., et al.</Author>
      <Journal>Protein Sci.(2009)18:2454-2470</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19780048?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE S-TRANSFERASE IN COMPLEX WITH GLUTATHIONE</PDB_Title>
      <PDB_ID>1AQW</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1AQW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor.</PubMed_Title>
      <Author>Prade, L., et al.</Author>
      <Journal>Structure(1997)5:1287-1295</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9351803?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE S-TRANSFERASE P1-1 COMPLEXED WITH CIBACRON BLUE</PDB_Title>
      <PDB_ID>20GS</PDB_ID>
      <Resolution>2.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=20GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The ligandin (non-substrate) binding site of human Pi class glutathione transferase is located in the electrophile binding site (H-site).</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>J.Mol.Biol.(1999)291:913-926</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10452896?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN GLUTATHIONE S-TRANSFERASE P1-1 IN COMPLEX WITH ETHACRYNIC ACID-GLUTATHIONE CONJUGATE</PDB_Title>
      <PDB_ID>3GSS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GSS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The three-dimensional structure of the human Pi class glutathione transferase P1-1 in complex with the inhibitor ethacrynic acid and its glutathione conjugate.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>Biochemistry(1997)36:576-585</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9012673?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN GLUTATHIONE S-TRANSFERASE P1-1 IN COMPLEX WITH ETHACRYNIC ACID</PDB_Title>
      <PDB_ID>2GSS</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GSS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The three-dimensional structure of the human Pi class glutathione transferase P1-1 in complex with the inhibitor ethacrynic acid and its glutathione conjugate.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>Biochemistry(1997)36:576-585</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9012673?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN GLUTATHIONE S-TRANSFERASE P1-1 Y108F MUTANT</PDB_Title>
      <PDB_ID>4GSS</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4GSS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Multifunctional role of Tyr 108 in the catalytic mechanism of human glutathione transferase P1-1. Crystallographic and kinetic studies on the Y108F mutant enzyme.</PubMed_Title>
      <Author>Lo Bello, M., et al.</Author>
      <Journal>Biochemistry(1997)36:6207-6217</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9166793?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural basis for the binding of the anti-cancer compound 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) to human glutathione S-transferases</PDB_Title>
      <PDB_ID>3IE3</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3IE3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases</PubMed_Title>
      <Author>Federici, L., et al.</Author>
      <Journal>Cancer Res.(2009)69:8025-8034</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19808963?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>A folding mutant of human class pi glutathione transferase, created by mutating aspartate 153 of the wild-type protein to glutamate</PDB_Title>
      <PDB_ID>1PX7</PDB_ID>
      <Resolution>2.03</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1PX7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The multi-functional role of a highly conserved aspartic acid residue in glutathione transferase P1-1</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Glutathione Transferase Pi in Complex with Dinitrosyl-diglutathionyl Iron Complex</PDB_Title>
      <PDB_ID>1ZGN</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ZGN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Nitrosylation of human glutathione transferase P1-1 with dinitrosyl diglutathionyl iron complex in vitro and in vivo</PubMed_Title>
      <Author>Cesareo, E., et al.</Author>
      <Journal>J.Biol.Chem.(2005)280:42172-42180</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16195232?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF PI CLASS GLUTATHIONE TRANSFERASE</PDB_Title>
      <PDB_ID>1EOG</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1EOG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of thermolabile mutants of human glutathione transferase P1-1.</PubMed_Title>
      <Author>Rossjohn, J., et al.</Author>
      <Journal>J.Mol.Biol.(2000)302:295-302</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10970734?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>GLUTATHIONE S-TRANSFERASE P1-1 APO FORM 1</PDB_Title>
      <PDB_ID>14GS</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=14GS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Evidence for an induced-fit mechanism operating in pi class glutathione transferases.</PubMed_Title>
      <Author>Oakley, A.J., et al.</Author>
      <Journal>Biochemistry(1998)37:9912-9917</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9665696?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human Glutathione Transferase Pi Y108V mutant</PDB_Title>
      <PDB_ID>3HJM</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HJM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Influence of the H-site residue 108 on human glutathione transferase P1-1 ligand binding: structure-thermodynamic relationships and thermal stability.</PubMed_Title>
      <Author>Quesada-Soriano, I., et al.</Author>
      <Journal>Protein Sci.(2009)18:2454-2470</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19780048?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Human Apo GST Pi C47S/Y108V Double Mutant</PDB_Title>
      <PDB_ID>3KMN</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KMN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Diuretic drug binding to human glutathione transferase P1-1: potential role of CYS101 revealed in the double mutant C47S/Y108V</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the Human GST Pi C47S/Y108V Double Mutant in Complex with the Ethacrynic Acid-Glutathione Conjugate</PDB_Title>
      <PDB_ID>3KM6</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KM6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Diuretic drug binding to human glutathione transferase P1-1: potential role of Cys-101 revealed in the double mutant C47S/Y108V.</PubMed_Title>
      <Author>Quesada-Soriano, I., et al.</Author>
      <Journal>J.Mol.Recognit.24:220-234</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20540076?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the glutathione transferase PI enzyme in complex with the bifunctional inhibitor, etharapta</PDB_Title>
      <PDB_ID>3DGQ</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DGQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Rational design of an organometallic glutathione transferase inhibitor</PubMed_Title>
      <Author>Ang, W.H., et al.</Author>
      <Journal>Angew.Chem.Int.Ed.Engl.(2009)48:3854-3857</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19396894?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00480</Pathway_ID>
      <Pathway_Title>Glutathione metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Metabolism of other amino acids</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05204</Pathway_ID>
      <Pathway_Title>Chemical carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05204</Pathway_ID>
      <Pathway_Title>Chemical carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05204</Pathway_ID>
      <Pathway_Title>Chemical carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05204</Pathway_ID>
      <Pathway_Title>Chemical carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00982</Pathway_ID>
      <Pathway_Title>Drug metabolism - cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <CATH_Class>Class 1: Mainly Alpha </CATH_Class>
    <CATH_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.b.gb.b.b.b.html</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Hegazy UM, et al. J Mol Biol. 2013,425(9):1509-1514. </Site_Reference>
      <Site_Type>Molecular rearrangement</Site_Type>
      <PubMed_ID>23399543</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.5.1.18</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/5/1/18.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD10490001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2013-05-24</Create_Date>
</Organism_Record>